Excelsior Biopharma Strategic Asset Allocation Index
Excelsior Biopharma strategic asset allocation index. Excelsior Biopharma (6496) has a Strategic Asset Allocation Index of 13.6% as of December 2022. Strategic assets (PP&E of NT$164.61 Million plus long-term investments of NT$-) total NT$164.61 Million, measured against net assets of NT$1.21 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Excelsior Biopharma net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Excelsior Biopharma (2017–2022)
Strategic asset allocation index of Excelsior Biopharma from 2017 to 2022. This chart shows how Excelsior Biopharma's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of December 2022, the index stands at 13.6%, representing strategic assets of NT$164.61 Million against net assets of NT$1.21 Billion TWD. Check tangible net worth ratio of Excelsior Biopharma to evaluate the tangible quality of the company's equity base.
Excelsior Biopharma Strategic Asset Allocation Index by Year (2017–2022)
Excelsior Biopharma strategic asset allocation index by year from 2017 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Excelsior Biopharma from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Excelsior Biopharma stock valuation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 13.6% | NT$164.61 Million | NT$164.61 Million | NT$- | NT$1.21 Billion | ▼ -1.7 pp |
| 2021 | 15.3% | NT$188.08 Million | NT$188.08 Million | NT$- | NT$1.23 Billion | ▼ -1.4 pp |
| 2020 | 16.7% | NT$214.31 Million | NT$214.31 Million | NT$- | NT$1.28 Billion | ▼ -0.9 pp |
| 2019 | 17.6% | NT$220.67 Million | NT$220.67 Million | NT$- | NT$1.25 Billion | ▲ +7.7 pp |
| 2018 | 9.9% | NT$135.30 Million | NT$135.30 Million | NT$- | NT$1.37 Billion | ▼ -1.3 pp |
| 2017 | 11.2% | NT$149.61 Million | NT$149.61 Million | NT$- | NT$1.34 Billion | — |